GLP
Novo Nordisk submits application for FDA approval of CagriSema for weight management
Novo Nordisk submits NDA to US FDA for once-weekly CagriSema for weight management based on REDEFINE trials.
EMA approves Mounjaro’s use for children as young as ten for diabetes management
EMA recommends Mounjaro for children aged 10+ with type 2 diabetes to improve blood sugar and aid weight loss.
Tirzepatide: Dual Action for Weight Loss
Compare tirzepatide and semaglutide weight-loss effects, visceral fat reduction, side effects, and costs to decide which therapy fits your health priorities.
GLP-1 vs. Other Medications: Interaction Risks
How GLP-1 receptor agonists slow gastric emptying and alter absorption with insulin, contraceptives, cardiovascular and CNS drugs — risks, monitoring, and timing tips.
Get Weight Loss Medication Without Insurance Hassle
Learn how to access weight loss medications like Ozempic through an easy, fast, online process without traditional insurance obstacles.
GLP-1 Injection Site Reactions: Causes and Fixes
Why GLP-1 injections often cause brief redness, swelling, itching or lumps, how to prevent and treat them, and when to seek medical help.
7 Causes of Weight Loss Plateaus on GLP-1 Medications
Seven common reasons GLP-1 users hit weight-loss plateaus — from slowed metabolism and muscle loss to hidden calories, low activity, hormones, and dosing issues.
Why GLP-1 Medications Cause GI Issues
Explains how GLP-1 drugs slow gastric emptying and alter intestinal motility, causing nausea, vomiting, diarrhea, constipation and gallbladder risk, with management tips.
Tirzepatide Cost Barriers for Weight Loss
Overview of tirzepatide pricing, insurance coverage gaps, savings programs, and lower-cost alternatives to reduce out-of-pocket expenses.